Jim Cramer's Mad Money In-Depth Stock Picks, March 16

by: Miriam Metzinger

Stocks discussed in the in-depth session of Jim Cramer’s Mad Money TV program, Friday March 16. Click on a stock ticker for more analysis:

Caterpillar (NYSE:CAT) Terex (NYSE:TEX), Cummins (NYSE:CMI), Paccar (NASDAQ:PCAR) and Manitowoc (NYSE:MTW)

Cramer declares it a “travesty of a mockery of a sham” that Caterpillar lingers at $63.16 while TEX, CMI, PCAR and MTW are up. On the other hand, he thinks the low price on his top stock of the quarter is a “sale on a best-of-breed stock” which is down 14% year over year. He believes the market is mistaken in grouping CAT with sluggish housing instead of with natural resources. Cramer would “ride” up Caterpillar, which should benefit from rising commodity prices and the end of the yen carry trade which will take the edge off the competition. With a $7.5 million buyback, Cramer thinks the company could bring up its own stock.

Related: Todd Sullivan takes a closer look at Caterpillar.

Regeneron Pharmaceuticals (NASDAQ:REGN), Nastech Pharmaceutical (NSTK)

Cramer told the story of REGN, which was sitting at $5 two years ago, hit $24 and has settked at $18. This gain was accomplished with revenue decline and without a “concrete” product. Cramer predicts NSTK will be the next REGN, and although it is considered a "a comedy of errors” and doesn’t have a new drug in the pipeline, NSTK has money in the bank and the advantage that biotech trades “on hope.” In addition, Cramer noted the company has an effective obesity and insulin drug and has the only “pure play” on autism. Cramer urged interested investors to do homework on NSTK and use limit orders when buying.

Related: H.S Ayoub reports on the phase one test of NSTK's insulin spray.

Game Plan for the coming week: National CineMedia (NASDAQ:NCMI), Verizon (NYSE:VZ), AT&T (NYSE:T), Sprint (NYSE:S), and Qwest (NYSE:Q), AAR (NYSE:AIR), General Mills (NYSE:GIS), Goldman Sachs (NYSE:GS)

On Monday, Cramer would buy NCMI, a “fast growing” company that makes cinema ads, and he notes NCMI has not moved since it went public. Concerning a $20 billion government phone contract reported in The Washington Post, Cramer believes Q is the most likely candidate, since T and VZ are too big and S is high because of takeover news. He suggested investors buy GS “hand over fist” on Monday because of its aggressive buyback plan, GIS ahead of its earnings on Thursday, and AIR before Wednesday.

CEO Interview: Peter van Stolk, Jones Soda's (OTCQB:JSDA)

When Cramer asked Peter van Stolk to account for Jone's great quarter, van Stolk credited his team’s hard work, strong sales and the introduction of the 12 ounce can; "I think the conversion to pure cane sugar is what's really taken it by the storm." Van Stolk said another advantage is “I can put [a photo] of your loved ones on a bottle of Jones Soda.” Competitors Coca-Cola and Pepsi lack the patent. Cramer thinks JSDA has more room to rise.

Related: Investor Tip on Jone's Soda: "Growth is Growth."

Seeking Alpha publishes a summary of Jim Cramer's stock picks every day including: Mad Money Recap, Lightning Round, Stop Trading and his Market Minute.

Get Cramer's Picks by email -- it's free and takes only a few seconds to sign up.

Seeking Alpha is not affiliated with Jim Cramer, CNBC or TheStreet.com

About this article:

Problem with this article? Please tell us. Disagree with this article? .